425: Strive-Semler Scientific Merger Communication

Strive, Inc. has filed a communication regarding its proposed business combination with Semler Scientific, Inc., highlighting strategic benefits and associated risks.

Summary

• The communication was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on November 12, 2025.
• It pertains to Strive's proposed business combination with Semler Scientific, Inc.
• The filing includes a cautionary statement regarding forward-looking statements, outlining inherent risks and uncertainties associated with the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus for important information about the transaction.
• Details are provided on where to obtain these and other relevant documents filed with the SEC, free of charge, from the SEC's website, Strive's website, or Semler Scientific's website.

Sentiment

Score: 6

Explanation: The filing communicates a significant strategic event (merger) which is generally positive, but it is heavily weighted with cautionary statements and extensive risk disclosures, leading to a neutral-to-slightly-positive sentiment for the event itself, balanced by the procedural and risk-focused nature of the document.

Positives

• Anticipated strategic benefits of the proposed transaction.
• Expected financial benefits of the proposed transaction.
• Anticipated cost savings from the integration of the two companies.
• Anticipated strategic gains from the integration of the two companies.

Negatives

• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

Strive and Semler Scientific have expectations regarding the proposed transaction, including anticipated strategic and financial benefits, the timing of closing, and the successful integration of combined businesses. However, these forward-looking statements are based on assumptions and are subject to various risks and uncertainties that could cause actual results to differ materially.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted the communication on X.com on November 12, 2025.
• Management of Strive and Semler Scientific hold opinions or judgments about future events related to the proposed transaction.

Industry Context

The filing mentions 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets,' suggesting that the combined entity may be involved in or exposed to the digital asset space, reflecting a growing trend among companies to explore or adopt digital asset strategies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is a potential risk.

Stakeholder Impact

• Shareholders: Potential dilution for Strive shareholders due to the issuance of additional Class A common stock.
• Customers: Potential adverse reactions from Strive's or Semler Scientific's customers.
• Employees: Potential changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Semler Scientific stockholders will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.

Key Dates

Keywords

Strive Inc, Semler Scientific Inc, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Corporate Governance, Bitcoin Treasury Strategy, Digital Assets